Skip to main content

Table 2. Result of proposed accuracy study

From: A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form

Level

Initial conc. (μg/ml)

Perindopril erbumine

Indapamide

Amlodipine besylate

% Spiked

PER

IND

AML

Area ± SD (n=3)

%Recovery± SD (n=3)

Area ± SD (n=3)

%Recovery± SD (n=3)

Area ± SD (n=3)

%Recovery ± SD (n=3)

0%

2.8

0.88

3.5

70004.0 ± 118.57

99.53 ± 0.19

77693.0 ± 617.07

100.89 ± 0.83

135263.3 ± 579.01

100.78 ± 0.46

80%

2.8

0.88

3.5

120086.3 ± 890.59

100.17 ± 1.43

136565.7 ± 518.23

99.49 ± 0.69

23.5430.3 ± 1146.05

100.01 ± 0.90

100%

2.8

0.88

3.5

132643.3 ± 565.76

100.39 ± 0.91

151712.0 ± 410.20

99.71 ± 0.55

260573.0 ± 668.8

99.90 ± 0.53

120%

2.8

0.88

3.5

145265.0 ± 373.10

100.71 ± 0.60

166581.0 ± 906.93

99.57 ± 1.21

286747.7 ± 956.7

100.60 ± 0.76